Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data

PURPOSE: During preclinical testing, teriparatide caused a dose‐dependent increase in the incidence of osteosarcoma in rats. This study compared the incidence rate of osteosarcoma among patients aged ≥65 years treated with teriparatide vs a matched‐comparator cohort. METHODS: This population‐based c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilsenan, Alicia, Midkiff, Kirk, Harris, David, McQuay, Lisa, Hunter, Shannon, Kellier‐Steele, Nicole, Andrews, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754479/
https://www.ncbi.nlm.nih.gov/pubmed/32894794
http://dx.doi.org/10.1002/pds.5103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754479/
https://www.ncbi.nlm.nih.gov/pubmed/32894794
http://dx.doi.org/10.1002/pds.5103

Ejemplares similares